{"title":"皮下避孕植入物","authors":"E. Oloto, L. Mascarenhas","doi":"10.1783/147118900101194454","DOIUrl":null,"url":null,"abstract":"Subdermal contraceptive implants are an additional approach to meeting the world-wide need for more effective and acceptable birth control. They provide long-acting, highly effective and reversible contraception by achieving low and stable concentrations of synthetic progestogens and require little user compliance, thereby achieving user failure rates that are similar to the method failure rates.1,2","PeriodicalId":22378,"journal":{"name":"The British journal of family planning","volume":"94 1","pages":"171 - 174"},"PeriodicalIF":0.0000,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"21","resultStr":"{\"title\":\"Subdermal contraceptive implants\",\"authors\":\"E. Oloto, L. Mascarenhas\",\"doi\":\"10.1783/147118900101194454\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Subdermal contraceptive implants are an additional approach to meeting the world-wide need for more effective and acceptable birth control. They provide long-acting, highly effective and reversible contraception by achieving low and stable concentrations of synthetic progestogens and require little user compliance, thereby achieving user failure rates that are similar to the method failure rates.1,2\",\"PeriodicalId\":22378,\"journal\":{\"name\":\"The British journal of family planning\",\"volume\":\"94 1\",\"pages\":\"171 - 174\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"21\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The British journal of family planning\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1783/147118900101194454\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British journal of family planning","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1783/147118900101194454","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Subdermal contraceptive implants are an additional approach to meeting the world-wide need for more effective and acceptable birth control. They provide long-acting, highly effective and reversible contraception by achieving low and stable concentrations of synthetic progestogens and require little user compliance, thereby achieving user failure rates that are similar to the method failure rates.1,2